The architecture of cancer.
- 28 November 1992
- Vol. 305 (6865) , 1306-1307
- https://doi.org/10.1136/bmj.305.6865.1306
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseasesTrends in Biotechnology, 1992
- Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the OvaryThe American Journal of Surgical Pathology, 1992
- Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumoursInternational Journal of Cancer, 1991
- The Role of the Matrix Metalloproteinase Stromelysin in the Progression of Squamous Cell CarcinomasThe Lancet Healthy Longevity, 1991
- Increased proteinase expression during tumor progression of tissue inhibitor of metalloproteinases cell lines down-modulated for levels: a new transformation paradigm?Zeitschrift für Krebsforschung und Klinische Onkologie, 1991
- Inhibition of collagenolytic activity in human leukemic K562 cells by tamoxifenLeukemia Research, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Induction of Growth Factor‐receptor and Metalloproteinase Genes by Epidermal Growth Factor and/or Transforming Growth Factor‐α in Human Gastric Carcinoma Cell Line MKN‐28Japanese Journal of Cancer Research, 1990
- Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factorCell, 1987
- Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activityNature, 1985